Expect Buzz About Vowst, a New Oral Fecal Microbiota Product

August 2023

Rx Vowst will be the first ORAL fecal microbiota product that’s FDA-approved for preventing C. diff recurrence in adults.

It comes on the heels of FDA approval of Rebyota...a fecal microbiota enema. Other fecal transplant products are investigational.

Any of these options may seem unappealing, but “transplanting” fecal microbiota can help restore a healthy GI flora.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote